Total trials
257
Active
62
Phase 3
0
Total enrollment
35,419
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| ıv morphine PCA | — | — | — | — | — | 3 | |
| IV morphine patient-controlled analgesia | — | — | — | — | — | 2 | |
| ibuprofen | — | — | — | — | — | 1 | |
| Magnesium Sulfate | — | — | — | — | — | 1 | |
| 0.9% Saline | — | — | — | — | — | 1 |
Next readouts
- 2026-08-01
- 2026-08-30
- 2026-09-01
- 2026-12-01
Top conditions
- Anesthesia16
- Anxiety12
- Postoperative Pain11
- Periodontitis9
- Analgesia8
- Acute Pain8
- Multiple Sclerosis8
- Pain6
Frequently asked questions about Ondokuz Mayıs University
- How many clinical trials does Ondokuz Mayıs University have on ClinicalTrials.gov?
- Ondokuz Mayıs University is listed as the lead sponsor on 257 clinical trials in ClinicalTrials.gov, 62 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ondokuz Mayıs University's trials are in Phase 3?
- 0 of Ondokuz Mayıs University's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Ondokuz Mayıs University focus on?
- Ondokuz Mayıs University's most-studied conditions on ClinicalTrials.gov are Anesthesia, Anxiety, Postoperative Pain, Periodontitis, Analgesia.
- When are Ondokuz Mayıs University's next clinical trial readouts?
- Ondokuz Mayıs University has 4 upcoming primary-completion readouts tracked here; the soonest is “Effect of Perioperative IV Ibuprofen on Cerebral Oxygenation and Postoperative Cognition During One-Lung Ventilation”, expected around 2026-08-01.